SITRYX THERAPEUTICS LIMITED
Research and experimental development on biotechnology
SITRYX THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
101 Bellhouse Building Magdalen Centre The Oxford Science Park Oxford OX4 4GA
Full company profile for SITRYX THERAPEUTICS LIMITED (10366466), an active life sciences and medical technology company based in Oxford, United Kingdom. Incorporated 8 Sept 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2017–2025)
Cash in Bank
£15.33M
Net Assets
£19.03M
Total Liabilities
£3.30M
Turnover
£3.01M
Employees
49
Debt Ratio
15%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (7)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 5 | Jan 2018 | Series B, Series A, Seed |
| Investor 1 | Oct 2018 | Series B, Series A |
| Investor 3 | Oct 2018 | Series B, Series A |
See all 7 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 20 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Professor Houman Ashrafian
Ceased 23 Jan 2018
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 30 Mar 2026 | Officers | Appointment of Dr Jeremy Griggs as director on 24 Mar 2026 | |
| 30 Mar 2026 | Officers | Termination of Garrett Rhyasen as director on 10 Mar 2026 | |
| 10 Mar 2026 | Resolution | Resolutions | |
| 23 Feb 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 4 Jan 2026 | Change Of Name | Replacement filing of SH01 - 01/05/25 Statement of Capital gbp 4508.8688 |
Appointment of Dr Jeremy Griggs as director on 24 Mar 2026
Termination of Garrett Rhyasen as director on 10 Mar 2026
Resolutions
Annual accounts made up to 31 Dec 2025
Replacement filing of SH01 - 01/05/25 Statement of Capital gbp 4508.8688
Recent Activity
Latest Activity
Appointment of Dr Jeremy Griggs as director on 24 Mar 2026
1 months ago on 30 Mar 2026
Termination of Garrett Rhyasen as director on 10 Mar 2026
1 months ago on 30 Mar 2026
Resolutions
2 months ago on 10 Mar 2026
Annual accounts made up to 31 Dec 2025
3 months ago on 23 Feb 2026
Replacement filing of SH01 - 01/05/25 Statement of Capital gbp 4508.8688
4 months ago on 4 Jan 2026